Stafford C T
Department of Medicine, Medical College of Georgia, Augusta 30912.
Postgrad Med. 1988 Sep 15;84(4):85-6, 91-6, 98. doi: 10.1080/00325481.1988.11700424.
The following management guidelines, based on changing concepts in asthma pathogenesis and treatment, outline an approach aimed at reducing asthma morbidity and mortality. Use of these guidelines may help to reduce airway hyperreactivity and result in improved care for these patients. Maintain open lines of communication between patient and physician. Promote positive patient-physician interaction. Remain alert for signs of psychological problems. Use maintenance antiinflammatory medications and bronchodilators as needed. Discuss medication requirements and possible side effects. Caution against abuse of beta agonists. Monitor drug diaries and theophylline levels to assess medication requirements and compliance with treatment. Monitor daily peak expiratory flow rates in patients prone to severe attacks of asthma. Encourage patients to report progressive symptoms or peak expiratory flow rates less than 200 liters/min. For asthma uncontrolled by bronchodilators and inhaled antiinflammatory medications, treat promptly with systemic corticosteroids.
以下管理指南基于哮喘发病机制和治疗方面不断变化的概念,概述了一种旨在降低哮喘发病率和死亡率的方法。使用这些指南可能有助于降低气道高反应性,并改善对这些患者的护理。保持患者与医生之间的沟通渠道畅通。促进积极的医患互动。警惕心理问题的迹象。根据需要使用维持性抗炎药物和支气管扩张剂。讨论药物需求和可能的副作用。注意避免滥用β受体激动剂。监测药物日记和茶碱水平,以评估药物需求和治疗依从性。监测易发生严重哮喘发作患者的每日呼气峰值流速。鼓励患者报告进行性症状或呼气峰值流速低于200升/分钟的情况。对于使用支气管扩张剂和吸入性抗炎药物无法控制的哮喘,及时用全身性皮质类固醇进行治疗。